Clinical trials
Phase 1 Leiomyoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 4 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Northwestern University | 2 |
| Advance Biofactures Corporation | 1 |
| American University of Beirut Medical Center | 1 |
| Chin-Jung Wang | 1 |
| Egymedicalpedia | 1 |
| GAAD Medical Research Institute Inc. | 1 |
| George Washington University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leiomyoma | 25 |
| Endometriosis | 6 |
| Myofibroma | 4 |
| Adenomyosis | 3 |
| Uterine Neoplasms | 2 |
| Dysmenorrhea | 1 |
| Genital Diseases, Female | 1 |
| Hemorrhage | 1 |
| Leiomyomatosis | 1 |
| Pelvic Pain | 1 |
Trials
Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.